Business Context and Reporting Period
Centene Corporation (CNC) filed a Form 8-K on September 11, 2025, to disclose participation in the Deutsche Bank 2025 Healthcare Summit. The filing serves as a Regulation FD disclosure regarding the Company's business and financial results through August 2025.
Key Financial Metrics
The filing does not provide specific GAAP revenue, profit, cash flow, or debt figures for the period ended August 2025. However, it confirms the following non-GAAP metric:
- Full Year 2025 Adjusted Diluted EPS Forecast: Approximately $1.75.
The Company states that results through August are consistent with this previously issued forecast. The filing notes that a reconciliation of this adjusted EPS forecast to the most directly comparable GAAP measure is not provided due to the difficulty of predicting the timing and amounts of various items.
Material Changes
No material changes to financial results or operations versus the prior comparable period are explicitly detailed in this filing. The document primarily reaffirms that current performance aligns with existing full-year expectations.
Guidance, Outlook, and Risks
Guidance and Outlook: Management reaffirmed the full-year 2025 adjusted diluted EPS forecast of approximately $1.75. The Company utilizes non-GAAP measures to evaluate core business performance, excluding amortization of acquired intangible assets and acquisition/divestiture-related expenses.
Risks and Contingencies: The filing includes an extensive list of forward-looking statement risks, including:
- Regulatory changes affecting government-sponsored healthcare programs (Medicaid, Medicare, ACA).
- Fluctuations in medical costs, inflation, and provider behaviors.
- Rate cuts or payment reductions by government payors.
- Challenges in maintaining CMS Star ratings and quality scores.
- Macroeconomic conditions, including interest rates and geopolitical events.
- Operational risks such as cyber-attacks, data security incidents, and third-party vendor compliance.
- Uncertainty regarding government shutdowns, debt ceilings, and funding.
Investor Verification Checklist
- Verify the full-year 2025 adjusted diluted EPS forecast of $1.75 against the Company's most recent 10-Q or 10-K filings.
- Review the specific non-GAAP adjustments (amortization, acquisition expenses) excluded from the adjusted EPS calculation.
- Monitor upcoming regulatory announcements regarding Medicaid/Medicare funding and ACA premium tax credits.
- Assess the impact of potential government shutdowns or debt ceiling issues on payment timelines.
- Check for updates on CMS Star ratings and their potential effect on future revenue.